Creo Medical Group PLC (LON:CREO – Get Free Report)’s share price reached a new 52-week low on Tuesday . The stock traded as low as GBX 15.50 ($0.20) and last traded at GBX 15.95 ($0.20), with a volume of 449749 shares changing hands. The stock had previously closed at GBX 16.13 ($0.20).
Creo Medical Group Price Performance
The stock has a market cap of £57.88 million, a PE ratio of -266.67 and a beta of 0.86. The business has a fifty day simple moving average of GBX 21.19 and a two-hundred day simple moving average of GBX 28.37. The company has a current ratio of 3.24, a quick ratio of 2.19 and a debt-to-equity ratio of 29.96.
Insider Buying and Selling
In related news, insider Richard John Rees purchased 98,000 shares of the company’s stock in a transaction dated Thursday, October 24th. The shares were purchased at an average cost of GBX 20 ($0.25) per share, with a total value of £19,600 ($24,847.87). Also, insider Kevin Crofton purchased 2,916,666 shares of the business’s stock in a transaction that occurred on Monday, October 21st. The stock was bought at an average price of GBX 24 ($0.30) per share, for a total transaction of £699,999.84 ($887,423.73). 22.43% of the stock is owned by insiders.
Creo Medical Group Company Profile
Creo Medical Group PLC, through its subsidiaries, researches, develops, manufactures, and sells medical devices and instruments in the United Kingdom. It is developing CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with flexible, accurate, and highly controllable devices delivered through a flexible endoscope.
Featured Stories
- Five stocks we like better than Creo Medical Group
- 3 Healthcare Dividend Stocks to Buy
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Technology Stocks Explained: Here’s What to Know About Tech
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Stock Sentiment Analysis: How it Works
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Creo Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creo Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.